BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Apollo Endosurgery, Inc. Reports Second Quarter 2018 Results

  OverStitch™ Product Sales Increase 37% Year-Over-Year

  August 8, 2018

   · 

  10 min read
• Genetown

  Kala Pharmaceuticals to Present at the Wedbush PacGrow Healthcare Conference

  Kala Pharmaceuticals, Inc. announced that it will present at the 2018 Wedbush PacGrow Healthcare Conference in New York, NY.

  August 8, 2018

   · 

  1 min read
• Business

  Five Prime Therapeutics Announces Second Quarter 2018 Financial Results

  Cabiralizumab continues to advance in randomized Phase 2 trial in pancreatic cancer

  August 8, 2018

   · 

  13 min read
• Biotech Beach

  Tandem Diabetes Care Announces Full Repayment of Outstanding CRG Debt

  Tandem Diabetes Care®, Inc. announced that it has fully repaid its term loan made by Capital Royalty Partners II L.P. and its affiliated funds (CRG).

  August 8, 2018

   · 

  4 min read
• Business

  Jamieson Wellness Inc. Reports Second Quarter 2018 Financial Results, Reiterates 2018 Guidance and Increases Quarterly Dividend

  Jamieson Wellness Inc. reported financial results for its second quarter ended June 30, 2018 and announced that the Company’s board of directors has authorized a 12.5% increase in the quarterly dividend.

  August 8, 2018

   · 

  18 min read
• Business

  INSYS Therapeutics Reports Second Quarter 2018 ResultsFocus remains on advancing pipeline across cannabinoid and spray platforms

  INSYS Therapeutics, Inc. reported financial results for its second quarter ended June 30, 2018.

  August 8, 2018

   · 

  13 min read
• Business

  Rigel Announces Second Quarter 2018 Financial Results and Provides Company Update

  $1.8 Million in Net Product Sales for TAVALISSE™ (fostamatinib disodium hexahydrate)

  August 8, 2018

   · 

  17 min read
• Business

  Synthetic Biologics Reports Second Quarter 2018 Operational Highlights and Financial Results

  SYN-004 End of Phase 2 Meeting with U.S. Food & Drug Administration on Track for Third Quarter of 2018

  August 8, 2018

   · 

  14 min read
• Business

  Nektar Therapeutics Reports Financial Results for the Second Quarter of 2018

  Nektar Therapeutics reported its financial results for the second quarter ended June 30, 2018.

  August 8, 2018

   · 

  24 min read
• Business

  Natera Reports Second Quarter 2018 Financial Results

  Natera, Inc. reported financial results for the second quarter ended June 30, 2018 and provided an update on recent business progress.

  August 8, 2018

   · 

  24 min read